ArQule to Report First Quarter 2013 Financial Results on May 8, 2013 Business Wire WOBURN, Mass. -- May 1, 2013 ArQule, Inc. (NASDAQ: ARQL) today announced that it will report its financial results for the first quarter of 2013 on Wednesday, May 8, 2013 at 7:00 a.m. Eastern Time. The Company will hold a conference call at 9:00 a.m. Eastern Time that day to discuss these results. Conference Call and Webcast Date: Wednesday, May 8, 2013 Time: 9:00 a.m., Eastern Time Conference Call Numbers Domestic (toll free): (877) 868-1831 International: (914) 495-8595 Webcast: www.arqule.com A replay of the conference call will be available beginning two hours after the completion of the call until the end of May 10, 2013 and can be accessed by dialing toll-free 855-859-2056 and outside the U.S. 404-537-3406. The confirmation code for replayed calls is 33189641. About ArQule ArQule is a biotechnology company engaged in the research and development of next-generation, small-molecule cancer therapeutics. The Company’s targeted, broad-spectrum products and research programs are focused on key biological processes that are central to human cancers. ArQule’s lead product, in Phase 2 and Phase 3 clinical development, is tivantinib (ARQ 197), an oral, selective inhibitor of the c-MET receptor tyrosine kinase. The Company’s pipeline includes: ARQ 092, designed to inhibit the AKT serine/threonine kinase; ARQ 087, designed to inhibit fibroblast growth factor receptor (FGFR); ARQ 621, designed to inhibit the Eg5 kinesin motor protein; and ARQ 736, designed to inhibit the RAF kinases. ArQule’s current discovery efforts, which are based on the ArQule Kinase Inhibitor Platform (AKIP™), are focused on the identification of novel kinase inhibitors that are potent, selective and do not compete with ATP (adenosine triphosphate) for binding to the kinase. Contact: ArQule, Inc. William B. Boni, 781-994-0300 VP, Investor Relations/ Corp. Communications www.ArQule.com
ArQule to Report First Quarter 2013 Financial Results on May 8, 2013
Press spacebar to pause and continue. Press esc to stop.